Autologous hematopoietic stem cell transplantation in tandem with anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma.

被引：0
|
作者：
Yang, Xiuxiu [1 ]
Zhang, Peiling [1 ]
Cao, Yang [1 ]
Wang, Jue [1 ]
Zhou, Mi [1 ]
Li, Chunrui [1 ]
Zhou, Jianfeng [1 ]
Huang, Liang [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7532
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Brentuximab vedotine: a new hope for children with relapsed or refractory CD30+ lymphoma
    Hamy, Aurelie Cabannes
    HEMATOLOGIE, 2018, 24 (06): : 339 - 340
  • [42] Autologous stem cell transplantation for CD30-positive anaplastic large cell lymphoma of the adult
    Fanin, R
    Silvestri, F
    Infanti, L
    Sperotto, A
    Geromin, A
    Cerno, M
    Stocchi, R
    Patriarca, F
    Zaja, F
    Damiani, D
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S179 - S179
  • [43] CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma
    Yu, Qiuxia
    Gang, Daizi
    Wang, Jue
    Huang, Liang
    Li, Chunrui
    Zhang, Yicheng
    Zhou, Xiaoxi
    Cao, Yang
    BLOOD, 2023, 142
  • [44] Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma
    Tuazon, Sherilyn A.
    Cassaday, Ryan D.
    Gooley, Theodore A.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Smith, Stephen D.
    Maloney, David G.
    Till, Brian G.
    Martin, Daniel B.
    Chow, Victor A.
    Rajendran, Joseph G.
    Fisher, Darrell R.
    Matesan, Manuela C.
    Lundberg, Sally J.
    Green, Damian J.
    Pagel, John M.
    Press, Oliver W.
    Gopal, Ajay K.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [45] Phase I/II study of the anti-CD30 antibody MDX-060 in patients with refractory/relapsed CD30 positive lymphoma
    Borchmann, P
    Ansell, S
    Byrd, J
    Horwitz, S
    Strair, R
    Khan, K
    Fischkoff, S
    Yellin, M
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 71 - 72
  • [46] Safety and Efficacy Profile of Autologous CD30.CAR-T-Cell Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (CHARIOT Trial)
    Ahmed, Sairah
    Flinn, Ian W.
    Mei, Matthew
    Riedell, Peter A.
    Armand, Philippe
    Grover, Natalie S.
    Engert, Andreas
    Lapteva, Natalia
    Nadler, Paul I.
    Myo, Aung
    Heslop, Helen E.
    BLOOD, 2021, 138 : 3847 - +
  • [47] A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+Lymphomas
    Grover, Natalie S.
    Park, Steven I.
    Ivanova, Anastasia
    Eldridge, Paul
    McKay, Kathryn
    Cheng, Catherine
    Laing, Spencer
    Covington, Deborah
    West, John
    Sharf, Elizabeth
    Morrison, J. Kaitlin
    Scott, Shaw
    Crecelius, Erin
    Shelley, Desirae
    Alexander, Maurice
    Buchanan, Faith Brianne
    Kassam, Emily
    McElfresh, Megan
    Pinto, Alicia
    Spruill, Angela
    Zanter, Ashley
    Wehner, Kimberly
    Dittus, Christopher
    Shea, Thomas C.
    Dotti, Gianpietro
    Serody, Jonathan S.
    Beaven, Anne
    Savoldo, Barbara
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [48] An anti-CD30 chimeric receptor that mediates CD3-ξ-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30
    Hombach, A
    Heuser, C
    Sircar, R
    Tillmann, T
    Diehl, V
    Pohl, C
    Abken, H
    CANCER RESEARCH, 1998, 58 (06) : 1116 - 1119
  • [49] Primary Cutaneous CD30+ Large T-Cell Lymphoma with Lymph Node and Cerebral Metastases
    Simal, E.
    Hoerndler, C.
    Porta, N.
    Baldellou, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (09): : 810 - 812
  • [50] CD30+ T-CELL INVOLVEMENT IN RHEUMATOID-ARTHRITIS SYNOVITIS
    GERLI, R
    MUSCAT, C
    BISTONI, O
    TOMASSINI, C
    AGEA, E
    BAGGINI, P
    BERTOTTO, A
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 498 - 498
12345